Have Insiders Sold USANA Health Sciences Shares Recently?

Some USANA Health Sciences, Inc. (NYSE:USNA) shareholders may be a little concerned to see that the Founder & Chairman Emeritus, Myron Wentz, recently sold a substantial US$713k worth of stock at a price of US$45.42 per share. However, that sale only accounted for 0.2% of their holding, so arguably it doesn't say much about their conviction.

View our latest analysis for USANA Health Sciences

USANA Health Sciences Insider Transactions Over The Last Year

Notably, that recent sale by Myron Wentz is the biggest insider sale of USANA Health Sciences shares that we've seen in the last year. So we know that an insider sold shares at around the present share price of US$44.96. While we don't usually like to see insider selling, it's more concerning if the sales take place at a lower price. We note that this sale took place at around the current price, so it isn't a major concern, though it's hardly a good sign.

Insiders in USANA Health Sciences didn't buy any shares in the last year. The chart below shows insider transactions (by companies and individuals) over the last year. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

For those who like to find hidden gems this free list of small cap companies with recent insider purchasing, could be just the ticket.

Insider Ownership Of USANA Health Sciences

Many investors like to check how much of a company is owned by insiders. A high insider ownership often makes company leadership more mindful of shareholder interests. USANA Health Sciences insiders own about US$357m worth of shares (which is 42% of the company). This kind of significant ownership by insiders does generally increase the chance that the company is run in the interest of all shareholders.

So What Does This Data Suggest About USANA Health Sciences Insiders?

Insiders haven't bought USANA Health Sciences stock in the last three months, but there was some selling. And there weren't any purchases to give us comfort, over the last year. The company boasts high insider ownership, but we're a little hesitant, given the history of share sales. So while it's helpful to know what insiders are doing in terms of buying or selling, it's also helpful to know the risks that a particular company is facing. For instance, we've identified 2 warning signs for USANA Health Sciences (1 is potentially serious) you should be aware of.

Of course USANA Health Sciences may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com